Icon

INTUNIV (nda022037)- (EQ 1MG BASE,EQ 2MG BASE,EQ 3MG BASE,EQ 4MG BASE)

GUANFACINE HYDROCHLORIDE TAKEDA PHARMS USA
EQ 1MG BASE,EQ 2MG BASE,EQ 3MG BASE,EQ 4MG BASE
Yes Yes
2023-Jan-04 Expired
None 2012-Sep-02
None No
INTUNIVĀ® is a central alpha2A-adrenergic receptor agonist indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications.
9 0 6
Total Other Developers 7
Drugs with Suitability No
EQ 1MG BASE ** ** - - 6
EQ 2MG BASE ** ** - - 6
EQ 3MG BASE ** ** - - 6
EQ 4MG BASE ** ** - - 6
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ********* ******* ********* *** *********** *** ****** ***, *********, *** ****** (**) *****, ****** ****** (***) ***
****** *** ****** *** ***************, ***. *********** **, **, **** ***, **** ***** **. *** ** ****., ****** ****, *****, ****** (***) ***
****** *** ****** *** ***************, ***. ******* ***** *********** *-*, ******* *** **., ******* ****, ******, ****** (***) ***
****** ****** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** *** ***** *** ************ ***. *********** ** ******** ****, *** *********, *** ****** (**) *****, ****** ****** (***) ***
****** *** ***** ******** ** *** *********** ******** ********** ** *****, *****, *****, ***** (***) ***
****** ******* ********* ******* ********* **** ***** ****** ***** *********** **. ***, ******* ****, *******, ***** ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.